Digital Fall Prevention for Fall

Phase-Based Progress Estimates
Brigham and Women's Hospital, Boston, MA
Digital Fall Prevention - CombinationProduct
All Sexes
What conditions do you have?

Study Summary

The Digital Fall Prevention Study is a single-group unblinded study to explore the feasibility and acceptability of a 3-month fall prevention exercise program delivered digitally via a tablet interface. Evidence-based exercise programs and motivational techniques will be used along with new wearable technology to predict fall risk.

Treatment Effectiveness

Study Objectives

5 Primary · 9 Secondary · Reporting Duration: at final (12-week) assessment

at final (12-week) assessment
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure (FIM)
Intervention Appropriateness Measure (IAM)
Technology Acceptance Model (TAM)
change from baseline to 12-weeks
Digit Symbol Substitution Test
Fall Efficacy Scale - International (FES-I)
Fried Frailty Index (FFI)
Grip Strength of dominant hand
Montreal Cognitive Assessment (MoCA)
Physical Activity Scale for the Elderly (PASE)
Sensor based fall risk assessment
Sensor based frailty assessment
Short Physical Performance Battery (SPPB)
Week 12
Acceptability and adherence to exercise program

Trial Safety

Trial Design

1 Treatment Group

Digital Fall Prevention
1 of 1
Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Digital Fall Prevention · No Placebo Group · Phase 1 & 2

Digital Fall Prevention
Experimental Group · 1 Intervention: Digital Fall Prevention · Intervention Types: CombinationProduct

Trial Logistics


Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at final (12-week) assessment
Closest Location: Brigham and Women's Hospital · Boston, MA
Photo of Boston 1Photo of Boston 2Photo of Boston 3
2008First Recorded Clinical Trial
3 TrialsResearching Fall
1051 CompletedClinical Trials

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,453 Previous Clinical Trials
9,701,214 Total Patients Enrolled
3 Trials studying Fall
29,995 Patients Enrolled for Fall
Best Buy Health, IncUNKNOWN
Kieran F Reid, PhDPrincipal InvestigatorBrigham and Women's Hospital

Eligibility Criteria

Age 65+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have fallen two or more times in the past year.
You have balance or walking problems.
Access to Wi-Fi in their home.
You have a minimum score of 17 on the MoCA.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.